Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

1999

Sanchez T, Moreno JJ. Ketoprofen S(+) enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures. Eur J Pharmacol. 1999;370(1):63-7.

Chadburn A, Frizzera G. Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma. Am J Clin Pathol. 1999;112(2):155-8.

Anwar F, Erice A, Jessurun J. Are there cytopathic features associated with cytomegalovirus infection predictive of resistance to antiviral therapy? Ann Diagn Pathol. 1999;3(1):19-22.

Rennert H, Golde T, Wilson RB, Spitalnik SL, Van Deerlin VM, Leonard DG. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization. Mol Diagn. 1999;4(3):195-209.

Rodgers W. Matrix metalloproteinases and carcinogenesis. Hum Pathol. 1999;30(4):363-4.

Signoretti S, Murphy M, Puddu P, DeCoteau JF, Faraggiana T, Kadin ME, et al. Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement. Diagn Mol Pathol. 1999;8(4):176-82.

Cesarman E, Knowles DM. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer Biol. 1999;9(3):165-74.

Chen KL, Wang YL, Rennert H, Joshi I, Mills JK, Leonard DG, et al. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. Am J Med Genet. 1999;85(5):463-9.

Prasad ML, Hyjek E, Giri DD, Ying L, O'Leary JJ, Hoda SA. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Am J Surg Pathol. 1999;23(2):176-81.

1998

Yang M, Loda M, Sytkowski AJ. Identification of genes expressed differentially by LNCaP or PC-3 prostate cancer cell lines. Cancer Res. 1998;58(16):3732-5.